Wanlong photoelectric: from the last five years gross profit, the average gross profit of the last five years 118 million yuan, the last five years, the lowest gross profit of 91.48 million yuan in 2018, the highest of 143.7 yuan in 2016 for 1 million yuan the company plans to produce COVID-19 temperature measurement gun. Shutai Shen: from the last five years gross profit, the average gross profit of the last five years 861 million dollars, the last five years gross profit as low as 347.6 million dollars in 2020 and as high as 1.333 billion dollars in 2016.
1, the company and its subsidiary De Fengrui application bdb-001 injection for the treatment of new coronavirus infection of severe pneumonia clinical trials and bdb-001 injection for the treatment of new coronavirus infection related diseases of the clinical trial application accepted by the State Drug Administration on January 31; the new coronavirus pneumonia (BDB-001) injection to obtain Hangzhou Hospital and the Ethics Committee of the Central Theater General Hospital of the Chinese People's Liberation Army approved. From the perspective of gross profit in the past five years, the average gross profit in the past five years was 424 million yuan. The lowest gross profit in the last five years was 292.8 million yuan in 2016, and the highest was 510.8 million yuan in 2020. disclosed on April 20, Xiamen Audiomac Medical Testing Company under the Ministry of Health undertook part of the COVID-19 nucleic acid testing service in Xiamen. The company's Xiamen McCurdy Testing Institute has nucleic acid testing qualifications, and is one of the designated institutions for viral nucleic acid testing in Xiamen.
2, huasheng biology: from the point of view of the gross profit in the past five years, the average gross profit in the past five years is 981 million yuan, in the past five years, the lowest gross profit of 310.3 million yuan in 2016, the highest is 253.9 202 million yuan. The new mRNA crown vaccine developed in cooperation with Suzhou Aibo has entered the clinical phase I. The new crown recombinant protein vaccine is distributed by the subsidiary Zerun Biologicals.ST Jinzhou: from the perspective of the gross profit in the past five years, the average gross profit of the past five years is 392 million yuan, and the gross profit in the past five years is as low as - 2,246 million yuan in 2020, and as high as 2,246 million yuan in 2016. 1.964 billion yuan. "Gold leaf jewelry" brand has won the Chinese gold and silver jewelry brand, Chinese famous brand, gold and silver jewelry top ten enterprises, China Jewelry and Jade Jewelry Industry Association executive director unit, vice president of the unit and many other honorary titles. China Gold Association member, Asia's top ten most influential brands, Asia China brand innovation champion.
3, Wanfu biology: from the perspective of the gross profit in the past five years, the average gross profit in the past five years is 1.075 billion yuan, the gross profit in the past five years is as low as 374.9 million yuan in 2016 and as high as 1.94 billion yuan. in February 2019, the new Coronavirus 2019-nCoV antibody detection kit (colloidal gold method) was formally approved by the State Pharmaceutical Administration of Inspection and Quarantine of the State Food and Drug Administration (AFPIQ) to obtain the certificate of registration of medical devices. It became the first officially approved COVID-19 antibody point detection reagents. Lutai A: From the perspective of the gross profit in the past five years, the average gross profit in the past five years was 1.791 billion yuan, and the gross profit in the past five years was as low as 1.013 billion yuan in 2020 and as high as 2.018 billion yuan in RMB 2018. Participating company Rongchang Pharmaceuticals 2.91% in the new crown vaccine research and development is progressing well, may cooperate with some multinational companies to carry out clinical trials.